Organic Anion Transporting Polypeptide 5A1 (OATP5A1) in Small Cell Lung Cancer (SCLC) Cells: Possible Involvement in Chemoresistance to Satraplatin

Ulrike Olszewski-Hamilton(Ludwig Boltzmann Institute for Cardiovascular Research), Gerhard Hamilton(Ludwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA), Veronika Buxhofer‐Ausch(Johannes Kepler University of Linz), Klaus Geißler(University of Vienna), M. Svoboda(University of Veterinary Sciences Brno), T. Thalhammer(Medical University of Vienna)
Biomarkers in Cancer
January 1, 2011
10.4137/bic.s7151
Cited by 21

Related Papers

Development and validation of an International Prognostic Score of thrombosis in World Health Organization–essential thrombocythemia (IPSET-thrombosis)
|Blood|2012|596
Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study
|Journal of Clinical Oncology|2011|540
Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients
|Blood|2011|448
Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study
|The Lancet Haematology|2020|351
Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia
|Blood Cancer Journal|2015|273